<DOC>
	<DOCNO>NCT01765920</DOCNO>
	<brief_summary>The purpose study : - ass safety liquid dosage form Ergoferon treatment acute upper respiratory tract infection adult patient . - assess clinical efficiency liquid dosage form Ergoferon treatment acute upper respiratory tract infection adult patient .</brief_summary>
	<brief_title>Clinical Trial Safety Clinical Efficiency Ergoferon Liquid Dosage Form Treatment Acute Upper Respiratory Tract Infections Adult Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>1 . Patients sex age 18 60 inclusively . 2 . Patients consult doctor increase seasonal incidence within 24 hour onset acute upper respiratory tract infection . 3 . Body temperature least 37.8 °С moment examination doctor . 4 . Presence two moderate level symptom three mild level symptom accord CCQ scale . 5 . The possibility start therapy within 24 hour onset first symptoms acute upper respiratory tract infection . 6 . Usage contraceptive method patient sex trial within 30 day end participation trial . 7 . Availability information sheet ( informed consent form take part clinical trial ) sign patient . 1 . Suspected invasive bacterial infection presence severe disease require use antibacterial drug ( include sulfanilamide ) . 2 . Suspected initial manifestation diseases symptom similar ARI ( infectious disease , flulike symptom onset systemic connective tissue disorder , oncohematological pathology ) . 3 . Exacerbation decompensation chronic disease affect patient 's ability participate clinical trial . 4 . Oncological disease . 5 . Medical history polyvalent allergy . 6 . Allergy / intolerance component medication use treatment . 7 . Impaired glucose tolerance , diabetes mellitus type 1 2 . 8 . Hereditary fructose intolerance ( due presence maltitol examine medicine ) . 9 . Intake medicine list section `` Prohibited concomitant treatment '' 1 month prior participation trial . 10 . Pregnancy , breast feeding . 11 . Drugs usage , alcohol usage amount 2 unit alcohol per day . 12 . Patients mental disorder . 13 . Patients , investigator 's point view fail comply observation requirement trial intake regimen investigate medicine . 14 . Participation clinical trial course 3 month prior inclusion present trial . 15 . Other factor , hinder patient 's participation trial ( example , plan trip business trip ) . 16 . The patient relate research personnel centre directly involve trial immediate family researcher . The immediate family include husband / wife , parent , child brother / sister , regardless whether natural adopt . 17 . The patient work OOO `` NPF `` Materia Medica Holding '' , i.e . s/he company 's employee , temporary contract worker , designate official responsible carry research immediate family .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>